PAVmed PAVM
NASDAQ PAVM
$1.65 +0.10 (+6.45%)
At close: Nov 6, 2026 · 4:00 PM EST

PAVmed (PAVM) Long-Term Debt Repayments (2019 - 2026)

Updated

PAVmed's Long-Term Debt Repayments came in at $531,000 for FY2024, up 572.2% from $79,000 in FY2023.

Analysis

PAVmed (PAVM) Long-Term Debt Repayments (2019 - 2026) Analysis & Trends

Going back to FY2018, PAVmed's Long-Term Debt Repayments data covers 7 years.

  • Long-Term Debt Repayments carries a five-year compound annual growth rate of 43.9% (FY2019 to FY2024).
  • The five-year range for annual Long-Term Debt Repayments is $79,000 (FY2023) to $14.82 million (FY2021).
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $79,000 in FY2023 (-98.7%), $6 million in FY2022 (-59.5%), $14.82 million in FY2021 (+13.6%) and $13.04 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn 1.11 Bn
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn 1.33 Bn
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn -
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn -
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn -
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn -
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn -
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn -
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn 2.00 Bn
10 PAVmed 9.87 Mn -5.01 Mn -89,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 11.15 Mn
Jun 30, 2024 209,000.00
Mar 31, 2024 322,000.00
Mar 31, 2021 14.82 Mn
Dec 31, 2019 -193,002.00
Jun 30, 2019 119,811.00
Mar 31, 2019 159,191.00
API Access

PAVmed Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PAVM&period=max&api_key=YOUR_API_KEY